S3 E6 - Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients?

S3 E6 - Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients?

In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown sit down with Rebecca Wilkins, divisional vice president of R&D for Abbott’s Neuromodulation business, to discuss the technologies Abbott is advancing for chronic pain and movement disorders.

Wilkins explains how Abbott’s spinal cord stimulation platforms, Proclaim™ DRG Neurostimulation System, and Infinity™ deep brain stimulation system are designed to interrupt errant nervous system signals, helping patients manage conditions ranging from chronic pain and Parkinson’s disease to, potentially, treatment-resistant depression.

The conversation also highlights the features shaping Abbott’s neuromodulation portfolio, including Bluetooth-enabled connectivity, the NeuroSphere™ Virtual Clinic for remote programming, improved MRI compatibility including prone MRI access, and device options that balance small size with low recharge demands.

Wilkins also shares new data presented at NANS showing significant reductions in pain-related healthcare encounters for patients using Abbott’s spinal cord stimulation and DRG therapies.

This episode is brought to you by Confluent Medical Technologies. To learn more about Confluent, visit: https://confluentmedical.com/. Make sure to catch Confluent's March DeviceTalks Tuesdays webinar highlighting its new technology, Filmcast Select™: https://event.on24.com/wcc/r/5241831/7E70E13249532E05CA8FB3D51421AD71?partnerref=confluent

***

Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters
  • (00:00:00) - Intro: Reflecting on Season 3
  • (00:05:22) - (Part 1) Interview with Confluent Medical's Brittany Mai
  • (00:07:56) - Keynote Interview: Rebecca Wilkins, DVP of R&D at Abbott’s neuromodulation business
  • (00:13:57) - A Personal Connection: How DBS Impacted a Family
  • (00:16:21) - Innovation in Connectivity: Bluetooth and NeuroSphere™ Virtual Clinic
  • (00:21:37) - (Part 2) Interview with Confluent Medical's Brittany Mai
  • (00:24:42) - Targeted Therapy: Understanding Spinal Cord and DRG Stimulation
  • (00:24:43) - Breaking Barriers: MRI Compatibility and Device Longevity
  • (00:36:04) - New Data from NANS: Validating Patient Outcomes

Episoder(18)

S3 E5 - How Abbott is rethinking heart failure management through smarter monitoring and long-term support

S3 E5 - How Abbott is rethinking heart failure management through smarter monitoring and long-term support

In this episode of AbbottTalks, hosts Tom Salemi and Kayleen Brown sit down with Dr. Finn Gustafsson, Chief Medical Officer for Abbott’s Heart Failure business, to discuss how Abbott’s technologies ar...

27 Okt 202550min

S3 E4 - How Abbott is rethinking mitral, tricuspid, and aortic solutions with next-generation innovation

S3 E4 - How Abbott is rethinking mitral, tricuspid, and aortic solutions with next-generation innovation

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Santosh Prabhu, PhD, Divisional Vice President of Product Development for Abbott’s Structural Heart business, to discus...

16 Sep 202534min

S3 E3 - Why Abbott’s vascular team sees AI as the GPS for the cath lab

S3 E3 - Why Abbott’s vascular team sees AI as the GPS for the cath lab

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business,...

19 Aug 202538min

S3 E2 - Can NeuroSphere’s connectivity deliver happier, healthier lives to more neuromodulation patients?

S3 E2 - Can NeuroSphere’s connectivity deliver happier, healthier lives to more neuromodulation patients?

In this episode of AbbottTalks, we dive into the surprising origins of neuromodulation, kicking off with a shocker (literally)—treating headaches with electric fish. Neuromodulation expert Yagna Patha...

3 Jun 202545min

S3 E1 - How Abbott built AVEIR™ DR pacemakers to be smaller, leadless, and able to talk with each other

S3 E1 - How Abbott built AVEIR™ DR pacemakers to be smaller, leadless, and able to talk with each other

AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders. Host Tom Salemi and new co-host Kayleen Brown welcome...

21 Apr 20251h 4min

S2 E7 - Abbott’s Sundareswaran envisions TEAM-HF & earlier interventions to redefine heart failure outcomes

S2 E7 - Abbott’s Sundareswaran envisions TEAM-HF & earlier interventions to redefine heart failure outcomes

In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott’s pioneering work in heart failure care, focusi...

17 Des 202456min

S2 E6 - Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

S2 E6 - Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip de...

22 Okt 202433min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
forklart
popradet
stopp-verden
fotballpodden-2
lydartikler-fra-aftenposten
rss-gukild-johaug
det-store-bildet
nokon-ma-ga
dine-penger-pengeradet
rss-ness
hanna-de-heldige
aftenbla-bla
rss-espen-lee-usensurert
rss-penger-polser-og-politikk
e24-podden
rss-dannet-uten-piano
frokostshowet-pa-p5